BioXcel Therapeutics Inc
Nasdaq BTAIQ · New Haven, CT
Works in GI & liver · Metabolic & endocrine · Neurology · Oncology · Psychiatry · Renal & urogenital
BioXcel Therapeutics Inc is a clinical trial sponsor based in New Haven, CT, listed as Nasdaq BTAIQ. It has 1 active clinical trial with 140 planned participants, across 6 therapeutic areas. Since 2021 it has completed 10 trials and stopped 4 early.
Trial track record · since 2021
Financials · Nasdaq BTAIQ
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about BioXcel Therapeutics Inc
BioXcel Therapeutics Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 140 planned participants, in GI & liver, Metabolic & endocrine, Neurology, Oncology and other areas. Since 2021 it has completed 10 trials and stopped 4 early.
BioXcel Therapeutics Inc is based in New Haven, CT and is listed as Nasdaq BTAIQ. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with BioXcel Therapeutics Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-05.
Approve Suite is not affiliated with BioXcel Therapeutics Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.